Trial Profile
Phase III clinical trial programme for RG 7128 planned.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2011
Price :
$35
*
At a glance
- Drugs Mericitabine (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Roche
- 07 Feb 2011 Roche added as company association
- 25 Nov 2010 New trial record